Steve Berman (lawyer)

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Evolv Technologies Holdings (EVLV) Investors to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Thursday, February 9, 2023
BBC, Gun, Safety, News, Person, School, BBC News, Student, Bomb, SAN, American depositary receipt, Weapon, Steve Berman (lawyer), Research, Television, Pharmaceutical industry, Evolving digital ecological network

SAN FRANCISCO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Hagens Berman is investigating possible misrepresentations concerning Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) technology claims and urges investors who purchased American Depositary Shares and suffered losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Hagens Berman is investigating possible misrepresentations concerning Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) technology claims and urges investors who purchased American Depositary Shares and suffered losses to submit your losses now .
  • The investigation focuses on Evolv’s claims regarding the effectiveness of its AI-based weapons detection technology for security screening.
  • “We’re focused on investors’ losses and whether Evolv may have put sales over safety and misled investors about the reliability of its technology,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • Whistleblowers: Persons with non-public information regarding Evolv Technologies should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Atlassian (TEAM) Investors with $500k+ Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

Retrieved on: 
Thursday, February 9, 2023
Growth, TEAM, Person, SAN, Steve Berman (lawyer), News, Pharmaceutical industry, Atlassian

SAN FRANCISCO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Atlassian Corporation (NASDAQ: TEAM) investors who suffered $500k or more in losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Atlassian Corporation (NASDAQ: TEAM) investors who suffered $500k or more in losses to submit your losses now .
  • Investors began to learn the truth on Nov. 3, 2022, when Atlassian announced disappointing Q1 2023 financial results.
  • “We’re focused on investors’ losses and proving Defendants misled investors about known adverse trends in Atlassian’s business,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Atlassian and have substantial losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

TWST FINAL DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Twist Bioscience (TWST) Investors with Losses to Contact Firm’s Attorneys to Feb. 10th Deadline in Securities Class Action

Retrieved on: 
Thursday, February 9, 2023
DNA, Charles Ponzi, Person, Complaint, Public expenditure, SAN, Scorpion, Growth, Fraud, Steve Berman (lawyer), Private investigator, Pharmaceutical industry

SAN FRANCISCO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now .
  • According to the Scorpion Report, Twist is perpetuating its fraud through false reporting of capital expenditures and gross margins—which Scorpion claims are actually negative.
  • “We’re focused on investors’ losses and proving Twist lied about its technology and true financial performance,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Twist and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages PLDT Inc. (PHI) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

Retrieved on: 
Tuesday, February 7, 2023
PHI, Person, Inquirer, Steve Berman (lawyer), PLDT, NYSE, Philippine Daily Inquirer, Public expenditure, SAN, Internet, P130, SGV, The Philadelphia Inquirer, Pharmaceutical industry

SAN FRANCISCO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges PLDT Inc. (NYSE: PHI) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges PLDT Inc. (NYSE: PHI) investors who suffered significant losses to submit your losses now .
  • PLDT Inc. (NYSE: PHI) Securities Fraud Class Action:
    The litigation focuses on PLDT’s past disclosures about capital expenditures incurred in its massive network transformation program.
  • “We’re focused on investors’ losses and proving PLDT misled investors about its CAPEX spend and controls associated with its network buildout,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in PLDT and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Credit Acceptance Corporation (CACC) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Monday, February 6, 2023
Credit, Person, Consumer, New Yorkers, Consumer Financial Protection Bureau, News, Credit Acceptance, SAN, NYAG, Steve Berman (lawyer), CACC, Bank, Risk management

SAN FRANCISCO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Credit Acceptance Corporation (NASDAQ: CACC) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Credit Acceptance Corporation (NASDAQ: CACC) investors who suffered significant losses to submit your losses now .
  • Credit Acceptance Corporation (CACC) Investigation:
    Credit Acceptance, one of the nation's largest subprime auto lenders, offers financing programs that enable auto dealers to sell vehicles to consumers regardless of their credit history.
  • This news drove the price of Credit Acceptance shares down over 11% on Jan. 4, 2023.
  • If you invested in Credit Acceptance and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

ENVX CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Enovix Corporation (ENVX) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Lawsuit Pending

Retrieved on: 
Monday, February 6, 2023
Person, Harrold, Complaint, Cybook Gen1, Silicon, SAN, Steve Berman (lawyer), Risk management, Pharmaceutical industry

SAN FRANCISCO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Enovix Corporation (NASDAQ: ENVX) investors who suffered significant losses to submit your losses now .
  • Enovix’s assurances began to come into question on Nov. 1, 2022, when the company announced disappointing Q3 revenues of just $8,000.
  • “We’re focused on investors’ losses and proving Enovix lied about the real Fab-1 and Gen1 capabilities,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Enovix and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

AVYA SECURITIES FRAUD: Hagens Berman, National Trial Attorneys, Encourages Avaya Holdings Corp. (AVYA) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Class Action Filed

Retrieved on: 
Monday, February 6, 2023
Person, NYSE, Software as a service, SAN, Audit committee, Ethics, Committee, AVYA, Steve Berman (lawyer), Audit, Pharmaceutical industry, Avaya

SAN FRANCISCO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Avaya Holdings Corp. (NYSE: AVYA) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Avaya Holdings Corp. (NYSE: AVYA) investors who suffered significant losses to submit your losses now .
  • “We’re focused on investors’ losses and proving Avaya misled investors about its controls and progress of its business model transformation,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Avaya and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Avaya should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

YMAB FRAUD ALERT: Hagens Berman, National Trial Attorneys, Encourages Y-mAbs Therapeutics (YMAB) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Class Action Filed

Retrieved on: 
Monday, February 6, 2023
Person, ODAC, Survival, BLA, SAN, FDA, Overalls, Steve Berman (lawyer), Therapy, Pharmaceutical industry, Medical device

SAN FRANCISCO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) investors who suffered significant losses to submit your losses now .
  • If you invested in Y-mAbs and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Y-mAbs should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.
  • For more information, call Reed Kathrein at 844-916-0895 or email [email protected] .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Class Action Filed

Retrieved on: 
Monday, February 6, 2023
Person, Complaint, Cancer, Destiny, FATE, News, CAR, Janssen, SAN, Workforce, Janssen Biotech, Steve Berman (lawyer), Therapy, Pharmaceutical industry

SAN FRANCISCO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Fate Therapeutics, Inc. (NASDAQ: FATE) investors who suffered significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Fate Therapeutics, Inc. (NASDAQ: FATE) investors who suffered significant losses to submit your losses now .
  • Under this agreement, Fate received a $50 million up front payment and was eligible to receive up to $3 billion in various milestone payments and royalties.
  • “We’re focused on investors’ losses and proving Fate misled investors about the strength of- and prospects for- its work with Janssen,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Fate Therapeutics and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages UP Fintech Holding (TIGR) Investors with Significant Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

Retrieved on: 
Monday, February 6, 2023
Person, Steve Berman (lawyer), The Wall Street Journal, News, Financial technology, WSJ, Growth, UP, TIGR, Bank, Pharmaceutical industry, PRC

UP Fintech Holding Limited (TIGR) Investigation:

Key Points: 
  • UP Fintech Holding Limited (TIGR) Investigation:
    The investigation focuses on UP Fintech’s statements about the sources and legality of its growth.
  • This news drove the price of UP Fintech American Depositary Receipts sharply lower on Dec. 30, 2022.
  • “We’re focused on investors’ losses and whether UP Fintech may have misled investors about whether sources of its growth were legal and sustainable,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in UP Fintech and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .